Severe Relapse of Vaccine-Induced Guillain-Barré Syndrome After Treatment With Nivolumab.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Neuromuscular Disease"
DOI: 10.1097/cnd.0000000000000230
Abstract: Cancer immunotherapy with checkpoint inhibitors may result in neuromuscular immune-related adverse reactions, including Guillain-Barré syndrome (GBS)-like disease. On the other hand, checkpoint inhibitor therapy may result in exacerbation of underlying autoimmune diseases such as myasthenia… read more here.
Keywords: treatment; relapse vaccine; barr syndrome; severe relapse ... See more keywords